Press release
Lawsuit filed for Investors in shares of Target Corporation (NYSE: TGT) over alleged Securities Laws Violations

A lawsuit was filed on behalf of investors in Target Corporation (NYSE: TGT) shares over alleged securities laws violations.
Investors who purchased shares of Target Corporation (NYSE: TGT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 30, 2023. NYSE: TGT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On May 18, 2022, Target Corporation announced results for the first fiscal quarter ended April 30, 2022, including that Fiscal 2022 second quarter gross margin for the quarter was 26.75%, down 426 basis points from the prior year. Target Corporation announced gross margins were primarily affected by unanticipated changes in consumer spending, as well as higher supply chain costs. Additionally, Target Corporation announced inventory was $15.08 billion, up approximately $1.1 billion compared to fourth fiscal quarter of 2021. Target Corporation explained inventories remained elevated versus expectations due to changing consumer spending habits. Target Corporation also announced that it was revising its fiscal year 2022 outlook, such that fiscal 2022 guidance concerning operating margin was lower to range centered around 6% from a margin rate of 8% or higher. Target Corporation attributed the guidance reduction, in part, to unexpected cost headwinds.
Shares of Target Corporation (NYSE: TGT) declined from $268.98 per share in November 2021 to as low as $137.16 per share on June 30, 2022.
The plaintiff claims that between August 18, 2021 and May 17, 2022, Target made materially false and/or misleading statements and/or failed to disclose: (i) the true extent of Target's difficulty maintaining a balanced inventory of in-demand goods, despite its insights into changing consumer preferences; (ii) that Target was severely impacted by changing consumer preferences; (iii) that Target's inventory mix was significantly more sensitive to changing consumer preferences due to Target's practice of buying larger quantities ahead of season, and was therefore at significant risk of having to use markdowns to sell out-of-demand goods; and (iv) that, as a direct result of these changing preferences, Target's inventory increasingly became out-of-balance and overweight in bulky and unsellable goods between August 18, 2021 and May 17, 2022forcing Target to markdown its out-of-demand goods, thereby negatively impacting revenue.
Those who purchased shares of Target Corporation (NYSE: TGT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors in shares of Target Corporation (NYSE: TGT) over alleged Securities Laws Violations here
News-ID: 3008719 • Views: …
More Releases from Shareholders Foundation

Investigation announced for Investors in InMode Ltd. (NASDAQ: INMD) over possibl …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of InMode Ltd.
Investors who are current long term investors in InMode Ltd. (NASDAQ: INMD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: INMD stocks follows a lawsuit filed against InMode Ltd. over…

Lawsuit Alert: Investors who lost money with shares of Revance Therapeutics, Inc …
An investor, who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC), filed a lawsuit over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, and / or those who purchased anyNASDAQ: RVNC shares prior to February 2024 and continue…

Lawsuit filed for Investors who lost money with shares of AstraZeneca PLC (NASDA …
An investor, who purchased shares of AstraZeneca PLC (NASDAQ: AZN), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by AstraZeneca PLC in connection with certain allegedly false and misleading statements made between February 23, 2022 and December 17, 2024.
Investors who purchased a significant amount of shares of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, have certain options and for certain…

Lawsuit filed for Investors who lost money with shares of Applied Therapeutics, …
An investor, who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT), filed a lawsuit over alleged violations of Federal Securities Laws by Applied Therapeutics, Inc.
Investors who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and for certain investors are short and strict deadlines running. Deadline: February 18, 2025. NASDAQ: APLT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
New York based Applied…
More Releases for Target
Depression Cannot Hit A Moving Target
Cottonwood Heights, Utah, Mar 12, 2020 -- Depression can't hit a moving target. That was a phrase to live by for Chelsea Hansen. She was full of life and love, and she had big goals. But soon she was to discover that life doesn't turn out the way she planned.
Behind the Fake Smile is a fictional book based on real-life experiences. It's the story of how Chelsea navigates a world…
Target Drones Market - Numerous Advantages Offered By Target Drones Over Unmanne …
Target drone can be defined as an unmanned remote controlled aerial vehicle, mostly utilized in the anti-aircraft crews training. The British DH.82 Queen Bee was one of the earliest drones and was a variant of the Tiger Moth trainer aircraft. Target drones are similar to radio-controlled model aircrafts. More modern drones may use countermeasures, radar, and similar systems to mimic manned aircraft. In the modern advanced drones, large, older missiles…
High Purity Aluminum Target Market
https://www.qandqmarketresearch.com/reports/7273640/high-purity-aluminum-target-market-80
The High Purity Aluminum Target market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for High Purity Aluminum Target.
This report presents the worldwide High Purity Aluminum Target…
Drug Discovery Outsourcing Market : Target Identification, Target Validation, Hi …
Global Drug Discovery Outsourcing Market: Overview
Drug discovery outsourcing involves a process of inventing a new medicine in the field of pharmaceuticals, biotechnology, and pharmacology. Drug discovery outsourcing is a complex, lengthy, and expensive process. Despite advanced technologies, success rate of drug discovery is very low and the time involved is relatively high. The process of drug discovery outsourcing involves target identification, target validation, high-speed screening, and lead optimization.
View Report: https://www.transparencymarketresearch.com/drug-discovery-outsourcing.html
The…
Sputtering Target Material Market Report 2018: Segmentation by Type (Metal Targe …
Global Sputtering Target Material market research report provides company profile for Praxair, Grikin, Plansee, Ningbo Jiangfeng, Honeywell, JX Nippon Mining & Metals Corporation, TOSOH, Sumitomo Chemical, Mitsui Mining & Smelting, ULVAC and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
BPOut stays on target
At the beginning of the year the BPOut announced the growth of the various teams, in Germany as well as internationally, as one of the most essential points of the strategy for 2014.
A short look back at the first quarter confirms that the company stays on target due to several new projects with existing clients in addition to the increase of A350 electrics team. This fact indicates the trust that…